Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,753 public trials 646 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients

NCT01332292

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Cypress, California, United States

GSK Investigational Site Huntington Beach, California, United States

GSK Investigational Site Denver, Colorado, United States

GSK Investigational Site Normal, Illinois, United States

View Trial Details

Completed

Vitamin D and Severe Asthma Exacerbations

NCT01921894

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

NCT01691508

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Denver, Colorado, United States

GSK Investigational Site New Haven, Connecticut, United States

GSK Investigational Site Rochester, Minnesota, United States

View all 47 locations

View Trial Details

Completed

Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet

NCT03087188

Conditions: Asthma, Bronchial Diseases, COPD, +13 more
Locations: University Hospital RWTH Aachen Aachen, North Rhine-Westphalia, Germany

View Trial Details

Completed

Serum Tryptase Levels During Cardiac Surgery, Diagnosis and Treatment Decisions for Allergic Reactions

NCT02644785

Conditions: Anaphylaxis, Cardiovascular Diseases, Hypersensitivity, +6 more
Locations: Mustafa Kemal University Hospital Antakya, Hatay, Turkey (Türkiye)

View Trial Details

Completed

Predicting Factors for Asthma Remission in Children

NCT02531503

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand

View Trial Details

Completed

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

NCT01105507

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +17 more
Locations: Alberta Children's Hospital, Department of Pediatrics Calgary, Canada

Queen Elizabeth II Hospital Halifax, Canada

View Trial Details

Completed

A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance

NCT01018693

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Novartis Investigator Site London, United Kingdom

View Trial Details

Completed

Inner-City Anti-IgE Therapy for Asthma

NCT00377572

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: University of Arizona Health Sciences Center Tucson, Arizona, United States

National Jewish Medical and Research Center Denver, Colorado, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Children's Memorial Hospital Chicago, Illinois, United States

View Trial Details

Completed

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

NCT01836471

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Novartis Investigative Site Encinitas, California, United States

Novartis Investigative Site Huntington Beach, California, United States

Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site Los Angeles, California, United States

View all 76 locations

View Trial Details